DNB Nordic Healthcare Prize 2019

As a leading Nordic Healthcare bank, DNB wants to contribute to an industry in growth in Norway and has established a healthcare prize for early-stage healthcare companies within Pharmaceuticals, Biotech, Diagnostics, Medtech and eHealth.

The semifinalists for the DNB Healthcare Prize 2019

Augere Medical AS, Bio-Me, BulbiTech AS, CardiNor AS, CIMON Medical AS, Diffia AS, Dignio AS, Nordic Brain Tech AS, Seald AS, ShieldME, SonoClear AS and UroBionics.

The finalists for the DNB Healthcare Prize 2019

For the fifth year in a row, the DNB Healthcare Prize will be presented at the DNB Nordic Healthcare Conference 2019, on the 12th of December. Six finalists will present and compete for the prize of NOK 1 million. DNB’s Trine Loe, Head of Future and Tech Industries, will announce the winner of the DNB Healthcare Prize 2019.

This years finalists:
- Augere Medical AS
- BulbiTech AS
- CIMON Medical AS
- Dignio A
- SonoClear AS
- UroBionics 

Who could apply?

Norwegian companies within:  
- Pharmaceuticals
- Biotech
- Diagnostics
- Medtech
- Digital Health (e-Health)

The company must be in a development phase and cannot be listed on a stock exchange. Companies engaged in nutrition, animals, marine technology, care services and hospital administration do not meet the application criteria.

What are the winning criteria?

Participating companies will be evaluated based on their innovation capacity, business potential and an ability to execute their strategy. In the semifinal and final, the companies are also judged on how they present and communicate their business case to the jury and investors.

Application deadline and process:

The deadline for applying is 13th of October 2019.

Week 43
12 companies will be chosen and get the opportunity to pitch at the semifinal, 6 November.

6th of November – semifinal
- Semifinal at Oslo Cancer Cluster.
- 12 semifinalists pitch a six-minute investor presentation to a jury.

8th of November
6 companies will be chosen and get the opportunity to pitch at the Finale, 12 December.

11th of November – pitch training for the group at DNB in Bjørvika

28th and 29th of November – individual pitch training for the finalists with our Start Up team at DNB in Bjørvika

28th and 29th of November – course in presentation skills
- Individual training in presentation skills by Ergo Ego.

12th of December - Final

- Training in presentation skills before the final.
- Six-minute pitch/investor presentation to a jury and an audience.
- Final and presentation of the DNB Healthcare Prize 2019 by DNB’s Trine Loe, Head of Future and Tech Industries, at DNB’s headquarters in Bjørvika, Oslo.

The jury of the DNB Healthcare Prize 2019

- Anders Tuv, Investment Director, Radforsk
- Joachim Paasche,  Entrepreneur in Residence, Sintef
- Michael Bodd, MD and Principal in Serendipity Partners
- Ingrid Akay Teigland, MD and Managing Partner Hadean Ventures
- Kari E. Krogstad, MSc Molecular Biology & CEO Medistim
- Christian Lütken, MD and Client Advisor, DNB Healthcare

Why is this a good opportunity?

The winner of the DNB Healthcare Prize will receive recognition and prize money of NOK 1 million to help in an early growth phase. Participants who reach the semifinal will hold a presentation for potential investors and the jury. The six finalists will receive professional training in presentation skills and present their company to a large audience.

We want to help more companies succeed
Healthcare is a sector with considerable growth potential and many companies in Norway have what it takes to succeed. DNB wishes to contribute long term to ensure that healthcare continues to grow as an industry in Norway.

DNB International Healthcare
We are the leading healthcare bank and among the largest healthcare banks in the United States. DNB International Healthcare has a portfolio with more than 50 international companies within Pharmaceuticals, Biotech, Medtech, Diagnostics and Digital Health (e-Health).

Contact information


Our business partners